Sentences with phrase «hemophilia drugmaker»

On Monday, French drugmaker Sanofi SA said it would buy U.S. - based hemophilia drugmaker Bioverativ Inc. for over $ 11.5 billion.
In the early hours of Monday morning, French drug giant Sanofi said it would buy hemophilia drugmaker Bioverativ, a Biogen spinout that is less than a year old, for $ 11.6 billion.

Not exact matches

In January, Sanofi agreed to acquire Biogen's hemophilia spinoff Bioverativ for $ 11.6 billion, and now the Japanese drugmaker Takeda is bidding for the rare - disease drugmaker Shire.
a b c d e f g h i j k l m n o p q r s t u v w x y z